MYCN and neuroblastoma: At diagnosis, NB cases are categorized into three risk groups, low, intermediate and high risk according to the International Neuroblastoma risk group (INRG) classification system on the basis of age at diagnosis, tumor stage, histopathology and molecular abnormalities including MYCN status and DNA copy number abnormalities (17).